Thrombotic thrombocytopenic purpura (TTP) rarely complicates acute inflammatory conditions such as surgery, including post-cardiac surgery. Review of 32 previously-reported cases of post-cardiac surgery TTP indicates that this disorder often occurs as early as 2-3 days following surgery, which seems too soon to implicate new formation of anti-ADAMTS13 autoantibodies as a consequence of surgery itself. We diagnosed post-cardiac surgery TTP in a 60-year-old female that began approximately 3 days post-coronary artery bypass surgery in which anti-ADAMTS13 autoantibodies were implicated. We therefore investigated whether anti-ADAMTS13 autoantibodies were also present in a blood sample. Inhibitory (neutralizing) anti-ADAMTS13 autoantibodies were detectable in the preoperative blood sample, suggesting that the role of surgery in precipitating TTP might be due to effects such as abrupt increase in postoperative von Willebrand factor levels and associated proinflammatory factors, rather than effects of surgery itself leading to the formation of de novo anti-ADAMTS13 autoantibodies.

Download full-text PDF

Source
http://dx.doi.org/10.1080/09537104.2021.1912314DOI Listing

Publication Analysis

Top Keywords

anti-adamts13 autoantibodies
24
post-cardiac surgery
16
surgery
9
thrombotic thrombocytopenic
8
thrombocytopenic purpura
8
surgery ttp
8
blood sample
8
anti-adamts13
6
autoantibodies
6
post-cardiac
4

Similar Publications

Allosteric regulation of ADAMTS13 (A Disintegrin And Metalloproteinase with ThromboSpondin type-1 motif, member 13) activity involves an interaction between its Spacer (S) and CUB1-2 domains to keep the enzyme in a closed, latent conformation. Monoclonal antibodies (mAb) uncouple the S-CUB interaction to open the ADAMTS13 conformation and thereby disrupt the global enzyme latency. The molecular mechanism behind this mAb-induced allostery remains poorly understood.

View Article and Find Full Text PDF

Refining the standard of care in immune thrombotic thrombocytopenic purpura.

Clin Adv Hematol Oncol

October 2024

Division of Hematology and Medical Oncology, NewYork-Presbyterian Hospital and Weill Cornell Medicine, New York, New York.

Article Synopsis
  • Acute immune thrombotic thrombocytopenic purpura (iTTP) is a serious condition that requires immediate medical attention and tests to see how it's affecting the blood.
  • Patients usually start treatment with plasma exchange (PE) and may also receive medications like glucocorticoids, rituximab, and caplacizumab to help improve their condition.
  • A study showed that using caplacizumab can reduce repeated episodes and speed up recovery, but there are some risks, like bleeding, which mostly get better on their own.
View Article and Find Full Text PDF

Autoantibodies to ADAMTS13 in human immunodeficiency virus-associated thrombotic thrombocytopenic purpura.

Vox Sang

December 2024

Department of Haematology and Cell Biology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa.

Background And Objectives: Thrombotic thrombocytopenic purpura (TTP) is a potentially fatal thrombotic microangiopathic disorder that can result from human immunodeficiency virus (HIV) infection. The pathogenesis involves a deficiency of the von Willebrand factor (vWF) cleaving protease ADAMTS13 (a disintegrin and metalloprotease with thrombospondin motifs member 13) and the presence of anti-ADAMTS13 autoantibodies. However, there is insufficient information regarding the epitope specificity and reactivity of these autoantibodies.

View Article and Find Full Text PDF
Article Synopsis
  • * Imaging studies revealed brain changes consistent with posterior reversible encephalopathy syndrome (PRES), leading to a complex diagnosis involving SS, ITTP, and PRES, treated with several medications including plasma exchange and rituximab.
  • * The case highlights the rare occurrence of ITTP and PRES as complications of SS, emphasizing the need for quick intervention with plasma exchange and the potential benefits of rituximab in such combined conditions.
View Article and Find Full Text PDF

Immune thrombotic thrombocytopenic purpura (iTTP) is a life-threatening thrombotic microangiopathy characterized by microangiopathic hemolytic anemia, thrombocytopenia, and ischemic end-organ injury due to microvascular platelet-rich thrombi. iTTP pathophysiology is based on a severe ADAMTS13 deficiency, the specific von Willebrand factor (vWF)-cleaving protease, due to anti-ADAMTS13 autoantibodies. Early diagnosis and treatment reduce the mortality.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!